MedPath

The Effect of tranexamic acid on the volume of bleeding during and after elective cesarean section in moderate and high risk patients

Phase 1
Conditions
Obstetrics and Gynecology diseases.
Encounter for care and examination of mother immediately after delivery
Z39.0
Registration Number
IRCT20211114053061N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

Term pregnant mothers who are candidates for elective caesarean section have medium and high risk for postpartum bleeding
Patients with history of postpartum hemorrhage in the past, presence of placenta previa, history of myomectomy, previous uterine surgery, multiple laparotomy, history of previous caesarean section more than 3 times, platelet count less than 75000, anemia with hemoglobin less than 10, polyhydramnios, macrosomia Weight more than 4000 grams, multiples, BMI more than 30, severe pregnancy complications such as preeclampsia

Exclusion Criteria

Unwillingness of patients to participate in the study and their infection with Corona
Hypersensitivity to tranexamic acid
VT Score more equal to 3
Underlying medical disease, placenta provia and placental adhesion disorders such as accreta and percreta, active bleeding and placental abruption, caesarean section with midline incision, drugs affecting tranexamic acid

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding volume. Timepoint: During surgery and 6 hours after surgery. Method of measurement: Collecting the amount of gas and liquid and bottle suction.;Hematocrit level. Timepoint: During surgery and 6 hours after surgery. Method of measurement: laboratory.
Secondary Outcome Measures
NameTimeMethod
Blood transfusion. Timepoint: After surgery. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath